James Garner

James Garner

Company: Kazia Therapeutics Limited

Job title: Chief Executive Officer


Panel Discussion: GBM AGILE Goes Worldwide: Taking a Deep Dive Into How Well It Has Worked So Far & What Promise It Brings With Expansion 9:30 am

Reflecting on more than 3 years of GBM AGILE – lessons learned to date and plans/goals for the next 3+ years Pharma perspectives of participation and stakeholder perspectives Learning from an annotated longitudinal database of screens from over 1300 glioblastoma patients What progress have we already seen with GBM AGILE so far? Conceptually, a ‘master…Read more

day: Conference Day One

PI3K Inhibition With Hypoinsulinaema – A Novel Approach to Maximizing the Impact of Targeted Therapy 11:30 am

Reviewing the role of the PI3K pathway in glioblastoma Evaluating the rationale for combining PI3K pathway inhibition with hypoinsulinaemia Overview of an ongoing clinical trial to explore the combinationRead more

day: Conference Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.